Skip to main content
TipRanks
Go Ultimate75% OFF

TG Therapeutics (NKB2) Q3 2022 Earnings Report

3 Followers

DE:NKB2 Q3 2022 EPS Results

Actual EPS
-EUR 0.23
Consensus EPS
-EUR 0.32
Beat/Miss
Beat by +EUR 0.09
One Year Ago EPS
-EUR 0.58

DE:NKB2 Q3 2022 Revenue Results

Actual Revenue
EUR 84.16K
Expected Revenue
EUR 1.30M
Beat/Miss
Missed by -EUR 1.22M
YoY Revenue Growth
-95.37%

Earnings Announcement Details

Quarter
Q3 2022
Date
11/10/2022
Time
Before Open
Conference Call
Thursday, November 10, 2022
DE:NKB2 Upcoming Earnings

TG Therapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.

Q3 2022 Earnings Call Audio

DE:NKB2 Q3 2022 Earnings Call
0:00 / 0:00

Q3 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:NKB2 Earnings History

DE:NKB2 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 02, 20272026 (Q4)0.47-0.13――
Nov 09, 20262026 (Q3)0.320.312.18-85.60% (-1.86)
Aug 03, 20262026 (Q2)0.270.040.15-70.59% (-0.11)
May 06, 20262026 (Q1)0.250.110.03300.00% (+0.08)
Feb 26, 20262025 (Q4)0.320.130.13-6.67% (-0.01)
Nov 03, 20252025 (Q3)0.202.180.0212050.00% (+2.16)
Aug 04, 20252025 (Q2)0.190.150.04325.00% (+0.12)
May 05, 20252025 (Q1)0.150.03-0.06142.86% (+0.09)
Mar 03, 20252024 (Q4)0.140.13-0.08266.67% (+0.21)
Nov 04, 20242024 (Q3)0.030.020.65-97.26% (-0.64)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed